Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Somchai Sriwiriyajan has a total of 27 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A Novel Antibiotic, Rhodomyrtone: Pharmacokinetic Studies in a Murine Model and Optimization and Validation of High-Performance Liquid Chromatographic Method for Plasma Analysis

    by Tan Suwandecha, Boon-Ek Yingyongnarongkul, Kanokkan Towtawin, Supayang Piyawan Voravuthikunchai, Somchai Sriwiriyajan

    Rhodomyrtone has indisputable and undeniable potential as a new antibiotic for antibiotic-resistant Gram-positive bacteria. Therefore, the main objective of this study was to determine the pharmacokinetics profiles of orally administered rhodomyrtone in rats. A reverse-phase HPLC-UV method was developed, optimized and validated for the analysis of rhodomyrtone concentrations in rat plasma. The retention time of papaverine and rhodomyrtone was 3.928 and 5.937 min, with no interference with the excipients used. The lower limit of quantification (LLOQ) of rhodomyrtone in the plasma sample was 0.04 μg/mL, the accuracy of rhodomyrtone at the LLOQ level ranged from 93.64 to 106.36%, precision was 6.59%, 80–120% for accuracy and <20% CV for precision. The calibration curve was linear at concentrations ranging from 0.04 to 128 µg/mL with a correlation coefficient (r) value of equal to or greater than 0.999. Sprague Dawley rats received a single dose of rhodomyrtone at 50 and 100 mg/kg. Blood samples were collected from tail veins. The peak plasma concentration was observed at 2 h, and the area under the curve of rhodomyrtone at 50 mg/kg and 100 mg/kg was 3.41 ± 1.04 and 7.82 ± 1.53 μg·h/mL, respectively. The results demonstrated linear pharmacokinetics characteristics at the studied dosage range. The plasma concentration of rhodomyrtone was above the minimal inhibition concentrations of several common pathogenic bacteria of medical importance. The proposed HPLC-UV method is fast, cost-effective, reliable and reproducible, and it is proposed for the routine analysis of rhodomyrtone.


  • Electrocardiogram Analysis for Kratom Users Utilizing Deep Residual Learning Network and Machine Learning

    by Kasikrit Damkliang, Jularat Chumnaul, Dania Cheaha, Somchai Sriwiriyajan, Ekkasit Kumarnsit

    Kratom ( Mitragyna speciosa Korth) is a common tropical plant found in Southeast Asia. Its leaves possess medicinal properties and are used to treat various ailments. However, the effects of kratom extract in terms of biological domains are still concerning. Although considerable studies have been conducted on the effects of kratom usage over the last few years, no study using in silico analysis of kratom users’ electrocardiogram (ECG) has been reported to date. This study aims to examine the long-term effects of kratom consumption using the ECG signals and deep learning (DL) network and machine learning techniques. Raw ECG signals were used as input for training and detecting abnormalities, and a deep residual learning network (DRLN) model was implemented to develop a feature extractor from single-lead datasets; the extracted features were used to train conventional machine learning classifiers. The confounding ECG abnormality factors, namely, age, sex, smoking, alcohol consumption, and exercise, were analyzed for association using the chi-square test. The main results of our study showed that kratom usage is not associated with ECG abnormalities. However, the ECG signal was affected more by gender than by the other factors; it exhibited the highest sensitivity and specificity (score $=$ 0.63). While this study is limited to ECG abnormalities, the results indicate that long-term usage of kratom for its health benefits may be considered a safe and natural practice.

  • Open Access

    Seasonal and Geographic Variation in Alkaloid Content of Kratom (Mitragyna speciosa (Korth.) Havil.) from Thailand

    by Narumon Sengnon, Phanita Vonghirundecha, Wiraphon Chaichan, Thaweesak Juengwatanatrakul, Jumpen Onthong, Pongmanat Kitprasong, Somchai Sriwiriyajan, Somsmorn Chittrakarn, Supattra Limsuwanchote, Juraithip Wungsintaweekul

    The objective of this study was to obtain data on the distribution of alkaloids in kratom plants grown in Thailand. Two collections were performed, covering the southern, central, and northern regions of Thailand and different seasons. The contents of alkaloids, including mitragynine (MG), paynantheine (PAY), and speciogynine (SG), were determined using the validated HPLC method. The 134 samples in the first collection were collected from Nam Phu subdistrict, Ban Na San, Surat Thani, Thailand, during June and October 2019 and January 2020. The maximum mitragynine content was 4.94% w/w in June (late summer), and the minimum content was 0.74% w/w in October (rainy season). To expand the study area after kratom decriminalization, 611 samples were collected in June–August 2021, October–December 2021, and January–April 2022. The accumulation of MG ranged from 0.35 to 3.46% w/w, 0.31 to 2.54% w/w, and 0.48 to 2.81% w/w, respectively. The meteorological data supported the climate’s effect on alkaloid production. Soil analysis revealed the importance of Ca and Mg in promoting alkaloid production. Geographical locations played a role in the variation of MG in kratom leaves, but did not affect the color of leaf veins. In conclusion, the present study suggested that the alkaloid content in kratom diverges based on seasonal and geographical origin.


  • Anti-cancer effects of Piper nigrum via inducing multiple molecular signaling in vivo and in vitro

    by Yan Deng, Somchai Sriwiriyajan, Aman Tedasen, Poonsit Hiransai, Potchanapond Graidist


  • Pharmacokinetic interactions between ciprofloxacin and itraconazole in healthy male volunteers

    by Somchai Sriwiriyajan, Maseetoh Samaeng, Wibool Ridtitid, Werawath Mahatthanatrakul, Malinee Wongnawa

    Objective.To investigate the pharmacokinetic interaction between ciprofloxacin and itraconazole in healthy male volunteers.Methods.Ten healthy male volunteers were assigned into a 2‐sequence, 3‐period pharmacokinetic interaction study. In phase 1, all subjects were randomly assigned to receive 500 mg of ciprofloxacin alone and 200 mg of itraconazole alone twice daily for 7 days with a 14 day wash‐out period in a crossover design. Phase 2 was performed 14 days after finishing phase 1, all subjects received 500 mg of ciprofloxacin in combination with 200 mg of itraconazole twice daily for 7 days. Ciprofloxacin and itraconazole pharmacokinetics were studied and adverse effects noted.Results.Ciprofloxacin significantly increased theCmaxandAUC0 − ∞of itraconazole by 53.13% and 82.46%, respectively. The half‐life andCLof itraconazole were not changed significantly. The combination of itraconazole and ciprofloxacin could therefore result in an increase in adverse drug reactions. Conversely, itraconazole had no significant effect on the pharmacokinetics of ciprofloxacin.Conclusion.Ciprofloxacin decreases the metabolism of itraconazole, most likely through inhibition of CYP3A4. The dosage of itraconazole should be reduced and its therapeutic outcome should be monitored closely when these two agents are concomitantly administered. Copyright © 2011 John Wiley & Sons, Ltd.


  • Development of an analytical method for cefpirome in plasma by simplified HPLC technique and its applications

    by Somchai Sriwiriyajan, Werawath Mahatthanatrakul

    The objective of this study was to develop a rapid and simplified, reliable high-performance liquid chromatography (HPLC) method for quantification of cefpirome (CAS 98753-19-6) in plasma. After precipitation of the plasma containing the internal standard, hydrochlorothiazide, with 5 % trichloroacetic acid (TCA), the analysis of the cefpirome level in the plasma samples was carried out using a reverse-phase C18 column with the ultraviolet detector set at a wavelength of 258 nm. The chromatographic separation was accomplished with an isocratic mobile phase consisting of acetonitrile-acetate buffer pH 5. The proposed method was specific and sensitive with a lower limit of quantitation (LLOQ) of 0.5 μg/ml. This HPLC method was validated by examining the precision and accuracy for inter- and intra-day analysis in the concentration range 0.5–64.0 μg/ml. The relative standard deviation in the inter-and intra-day validation was less than 3 %. Analytical recovery was more than 84 %, and cefpirome was found to be stable in human plasma during both the storage and assay procedures. A satisfactory pharmacokinetic study of cefpirome was carried out in rabbits using the devised procedure.